SonoThera Closes Oversubscribed $125 Million Series B Financing to Advance Clinical Development of Ultrasound-Mediated Nonviral Genetic Medicines. Learn more.
Ultrasound-mediated delivery of non-viral full-length dystrophin vector to skeletal, heart and diaphragm muscle tissues in DMD mice and non-human primates.